Home | Welcome to Contract Pharma   
Last Updated Saturday, November 1 2014
Print

Breaking News

Related Searches:
November 30, 2010
RiconPharma has acquired a cGMP pharmaceutical manufacturing company in Fairfield, NJ to be called Mirror Pharmaceuticals LLC.   Read More »
November 30, 2010
Array BioPharma has achieved a $10 million clinical research milestone in its collaboration with Celgene, with the planned initiation of a Phase I dose escalation trial in cancer patients with ARRY-382, a small molecule cFMS inhibitor.  Read More »
November 29, 2010
Almac has added a dedicated late stage customization suite to its commercial facilities in Europe.  Read More »
November 29, 2010
Pfizer and Protalix BioTherapeutics have submitted a Marketing Authorization Application to the EMA for taliglucerase alfa, a plant-cell expressed form of glucocerebrosidase (GCD), for the treatment of Gaucher disease.  Read More »
November 29, 2010
Accentia Biopharmaceuticals has entered a strategic agreement with Baxter Healthcare providing Accentia the exclusive, worldwide right to purchase Baxter’s cyclophosphamide — marketed under the brand name Cytoxan — for the treatment of a  Read More »
November 29, 2010
Quintiles and London Genetics have entered a strategic alliance to offer pharmacogenetics solutions to the biopharmaceutical industry in an effort to advance personalized medicine.  Read More »
November 24, 2010
GlaxoSmithKline will transfer ownership of its penicillin manufacturing site in Bristol, TN, and rights for the Augmentin and Amoxil brands in the U.S. to Dr. Reddy’s Laboratories.  Read More »
November 24, 2010
Eli Lilly and Co. and Acrux received approval from the FDA for Axiron (testosterone) topical solution CIII for replacement therapy in men for conditions associated with a deficiency or absence of testosterone.  Read More »
November 23, 2010
Francois (Frans) L. Dubois has been named to the newly created position of senior vice president of Quality at Hospira, Inc., effective Jan. 3, 2011.  Read More »
November 23, 2010
Abbott achieved positive results from a Phase II dose-ranging study of atrasentan, a highly selective endothelin A receptor antagonist in development to help slow chronic kidney disease (CKD) progression in patients with type 2 diabetic kidney disease.  Read More »
November 23, 2010
Evotec AG, through the NEU(2) consortium, has signed an agreement with Merck KGaA to develop pre-clinical candidates for an undisclosed neurological disease.   Read More »
November 22, 2010
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare achieved positive results from two parallel Phase III studies in patients with the neovascular form of age-related macular degeneration (wet AMD), with all regimens of VEGF Trap-Eye (aflibercept ophthal  Read More »
November 22, 2010
Edward Rowland has been appointed head of operational analytical services for Penn Pharma.   Read More »
November 22, 2010
Lancaster Laboratories has introduced a new cGMP compliant mycoplasma assay, harmonizing both United States Pharmacopeia (USP) Chapter <63> monograph and European Pharmacopoeia Chapter 2.6.7 guidelines.  Read More »
November 22, 2010
Boehringer Ingelheim and F-star, an antibody engineering company based in Vienna, Austria, have entered a collaboration and license agreement for the discovery of new antibody-derived therapeutic products using F-star’s Modular Antibody Technology.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On